Form 4: Precipio Director Sandberg Granted Stock Options

Precipio, Inc. Director Richard A. Sandberg received 1,500 stock options with an exercise price of $23.82, vesting monthly over one year.

Summary

• Richard A. Sandberg, a Director of Precipio, Inc. (PRPO), was granted 1,500 stock options.
• The transaction date for this grant was January 2, 2026.
• Each stock option has an exercise price of $23.82 per share.
• The options will vest in twelve equal monthly installments, commencing one month after the issuance date.
• The expiration date for these stock options is January 2, 2036.
• The grant was made under the Issuer's Equity Incentive Plan as compensation for Sandberg's service as a director.

Sentiment

Score: 6

Explanation: The filing reports a routine grant of stock options to a director, which is a standard compensation practice. This is generally viewed as a neutral to slightly positive event as it aligns director incentives with shareholder interests, but it does not indicate significant operational or financial news.

Positives

• The grant of stock options aligns the director's financial interests with those of the shareholders, incentivizing long-term company performance.
• The compensation is structured through an established Equity Incentive Plan, indicating a formal governance framework for executive and director remuneration.

Future Outlook

The filing does not contain forward-looking statements or guidance beyond the vesting schedule and expiration date of the granted options.

Industry Context

The grant of stock options to a director is a common practice in publicly traded companies across various industries, serving as a form of equity-based compensation to attract and retain talent and align management interests with shareholder value.

Comparison to Industry Standards

• Equity compensation, particularly through stock options, is a standard component of director remuneration in the U.S. public market, aligning with practices seen in companies like Apple (AAPL), Microsoft (MSFT), and Pfizer (PFE) which utilize similar incentive plans.
• The vesting schedule of twelve equal monthly installments over one year is a typical structure for such grants, designed to encourage continued service and long-term commitment, comparable to vesting schedules observed in many technology and biotech firms.

Corporate Governance

Related Party Transactions

• Grant of 1,500 stock options to Director Richard A. Sandberg as compensation for his service, pursuant to the Issuer's Equity Incentive Plan.

Stakeholder Impact

• Shareholders: The grant of options to a director can align management's interests with shareholder value creation, potentially leading to better long-term performance.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The stock options will begin vesting in twelve equal monthly installments starting one month after the grant date (approximately February 2, 2026).

Key Dates

Keywords

Precipio, PRPO, SEC Form 4, stock options, director compensation, insider transaction, equity incentive plan, beneficial ownership